InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-26.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Juda Scott, Director. Officer active across 1 company, notably Inmune Bio, Inc.. In total, 7 disclosures have been logged. Split: 5 buys · 0 sell. Total volume traded: €371k. Activity tracked since 17 November 2021. The latest transaction was filed on 2 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
14,801 shares@ US$1.40Common StockSEC:0001213900-26-075738:0
5,000 shares@ US$7.275.6% of flowCommon StockSEC:0001213900-24-055920:0
Ideal exit: 22 Mar 2025 (T+270)
29,603 shares@ US$8.3238.4% of flowCommon StockSEC:0001213900-24-035720:0
Ideal exit: 14 Jan 2025 (T+270)
29,603 shares@ US$8.3238.4% of flowCommon StockSEC:0001213900-24-035471:0
7,000 shares@ US$6.957.6% of flowCommon StockSEC:0001213900-23-085758:0
Ideal exit: 6 Aug 2024 (T+270)
2,500 shares@ US$13.550.073% mcap50.0% of flowCommon StockSEC:0001213900-21-060386:0
Ideal exit: 14 Aug 2022 (T+270)
2,500 shares@ US$13.555.0% of flowCommon StockSEC:0001213900-21-060386
Ideal exit: 14 Aug 2022 (T+270)
7 of 7 declarations
About Juda Scott
Scott Juda is a Director at Inmune Bio, Inc. In this role, he participates in strategic decision-making and governance of the company. His experience in the biotechnology sector allows him to provide valuable insights to the board.
